Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01286922 · ClinicalTrials.gov registry record · NA

The Insulin Sensitivity Using Aerobic Interval Conditioning

A NA study, sponsored by Pennington Biomedical Research Center.

Completed
Registry status
NA
Development phase
42
Enrollment target

NCT01286922: Completed NA study, sponsored by Pennington Biomedical Research Center.

NCT01286922 is a NA study that has completed, run by Pennington Biomedical Research Center. The registered enrollment target is 42 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01286922, a NA study, has completed, sponsored by Pennington Biomedical Research Center.

COMPLETED
Registry status
NA
Development phase
42 participants
Enrollment target

Study Summary

The Insulin Sensitivity using Aerobic Interval Conditioning (ISAIC) trial will compare traditional aerobic training (AER) to interval training (INT) in sedentary, overweight/obese men at risk for pre-diabetes. The investigators will randomly assign 42 individuals to 3 months of monitored exercise using a randomly assisgned design where participants will exercise under either AER or INT training conditions. The AER training condition will be consistent with "standard-of-care" recommendations. Exercise training will entail one 3-month blocks of either AER or INT. Training will consist of 1) a 1-month ramp up period, 2) 1-month of traditional aerobic training and 3) 1-month of either continued AER or INT.

Primary Outcome

Individulas randomized to INT will have greater improvements in insulin sensitivity than individuals assigned to traditional AER.

Interventions

  • OTHER Behavioral: exercise

Trial Details

FieldValue
Enrollment Target 42 participants
Start Date 2009-07
Est. Completion 2012-02
Phase NA

What the finished NCT01286922 record still lists

NCT01286922 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 42 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).

The record links to 0 conditions, and to 1 intervention - of which Behavioral: exercise is the first listed.

NCT01286922 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01286922 about?

NCT01286922 is a clinical study titled "The Insulin Sensitivity Using Aerobic Interval Conditioning". The Insulin Sensitivity using Aerobic Interval Conditioning (ISAIC) trial will compare traditional aerobic training (AER) to interval training (INT) in sedentary, overweight/obese men at risk for pre-diabetes. The investigators will randomly assign 42 individuals to 3 months of monitored exercise us...

What is the current status of trial NCT01286922?

This trial is currently completed. It is a NA study. The enrollment target is 42 participants. The study started on 2009-07. Estimated completion is 2012-02.

What interventions are being tested in trial NCT01286922?

The interventions under investigation include: Behavioral: exercise (OTHER).

Who is sponsoring clinical trial NCT01286922?

This trial is sponsored by Pennington Biomedical Research Center, which has 258 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01286922's enrollment target sits among peer trials

42 1436th of 2000 higher than 555 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02852213 · 42 participants · Phase 1

    A Single-Stage, Adaptive, Open-label, Dose Escalation Safety and Efficacy Study of AADC Deficiency in Pediatric Patients

  • NCT03136146 · 42 participants · Phase 2

    Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma, Burkitt Lymphoma/Leukemia, or Double-Hit Lymphoma/Leukemia

  • NCT03178149 · 42 participants · Phase 1

    A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degeneration

  • NCT03663530 · 42 participants · NA

    Circadian Misalignment and Energy Balance

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01286922, the US trial registry maintained by the National Library of Medicine. NCT01286922 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.